Literature DB >> 7971271

Exon2 of HIV-2 Tat contributes to transactivation of the HIV-2 LTR by increasing binding affinity to HIV-2 TAR RNA.

H Rhim1, A P Rice.   

Abstract

Human immunodeficiency virus types 1 and 2 (HIV-1 and HIV-2) express related Tat proteins that are encoded in two exons. Tat proteins bind directly to the TAR RNA element contained in the 5' ends of viral transcripts and thereby stimulate transcription through an as yet unidentified mechanism. We have investigated the functional significance of exon2 of the HIV-2 Tat protein by examining properties of proteins consisting of exon1 alone or exon1 + 2. In transactivation assays in vivo, exon2 modestly increased HIV-2 Tat stimulation of transcription from the HIV-2 long terminal repeat (LTR) but had no effect on transcription from the HIV-1 LTR. In HeLa cells, exon2 increased transactivation of the HIV-2 LTR by approximately three-fold, while in COS and Jurkat cells this value was less than two-fold. In binding assays in vitro, exon2 increased the binding affinity of the HIV-2 Tat protein to HIV-2 TAR RNA. Results with GAL4 fusion proteins and a synthetic promoter containing GAL4 DNA binding sites indicated that exon2 does not contribute to the HIV-2 Tat activation domain. These observations suggest that exon2 of HIV-2 Tat contributes to transactivation of the HIV-2 LTR by increasing the binding affinity to HIV-2 TAR RNA.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7971271      PMCID: PMC308473          DOI: 10.1093/nar/22.21.4405

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  50 in total

1.  Does the human immunodeficiency virus Tat trans-activator contain a discrete activation domain?

Authors:  L S Tiley; P H Brown; B R Cullen
Journal:  Virology       Date:  1990-10       Impact factor: 3.616

2.  Sequence-specific interaction of Tat protein and Tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1 in vitro.

Authors:  M G Cordingley; R L LaFemina; P L Callahan; J H Condra; V V Sardana; D J Graham; T M Nguyen; K LeGrow; L Gotlib; A J Schlabach
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

3.  The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation.

Authors:  M B Feinberg; D Baltimore; A D Frankel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

4.  Identification of lentivirus tat functional domains through generation of equine infectious anemia virus/human immunodeficiency virus type 1 tat gene chimeras.

Authors:  R Carroll; L Martarano; D Derse
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

5.  Analysis of arginine-rich peptides from the HIV Tat protein reveals unusual features of RNA-protein recognition.

Authors:  B J Calnan; S Biancalana; D Hudson; A D Frankel
Journal:  Genes Dev       Date:  1991-02       Impact factor: 11.361

Review 6.  The biochemistry of AIDS.

Authors:  Y N Vaishnav; F Wong-Staal
Journal:  Annu Rev Biochem       Date:  1991       Impact factor: 23.643

7.  The acidic amino-terminal region of the HIV-1 Tat protein constitutes an essential activating domain.

Authors:  J Rappaport; S J Lee; K Khalili; F Wong-Staal
Journal:  New Biol       Date:  1989-10

8.  A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation.

Authors:  S Roy; U Delling; C H Chen; C A Rosen; N Sonenberg
Journal:  Genes Dev       Date:  1990-08       Impact factor: 11.361

9.  Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein.

Authors:  J Kamine; T Subramanian; G Chinnadurai
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

10.  HIV-1 tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure.

Authors:  C Dingwall; I Ernberg; M J Gait; S M Green; S Heaphy; J Karn; A D Lowe; M Singh; M A Skinner
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

View more
  9 in total

1.  PITALRE, the catalytic subunit of TAK, is required for human immunodeficiency virus Tat transactivation in vivo.

Authors:  M O Gold; X Yang; C H Herrmann; A P Rice
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

2.  Antiapoptotic function of Cdk9 (TAK/P-TEFb) in U937 promonocytic cells.

Authors:  S M Foskett; R Ghose; D N Tang; D E Lewis; A P Rice
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

3.  Viral transactivators specifically target distinct cellular protein kinases that phosphorylate the RNA polymerase II C-terminal domain.

Authors:  C H Herrmann; M O Gold; A P Rice
Journal:  Nucleic Acids Res       Date:  1996-02-01       Impact factor: 16.971

4.  Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor.

Authors:  C H Herrmann; A P Rice
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

5.  The human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase II for function.

Authors:  X Yang; C H Herrmann; A P Rice
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

6.  Genetic diversity of simian immunodeficiency viruses from West African green monkeys: evidence of multiple genotypes within populations from the same geographical locale.

Authors:  F Bibollet-Ruche; C Brengues; A Galat-Luong; G Galat; X Pourrut; N Vidal; F Veas; J P Durand; G Cuny
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

7.  Modifications in host cell cytoskeleton structure and function mediated by intracellular HIV-1 Tat protein are greatly dependent on the second coding exon.

Authors:  M R López-Huertas; S Callejas; D Abia; E Mateos; A Dopazo; J Alcamí; M Coiras
Journal:  Nucleic Acids Res       Date:  2010-02-05       Impact factor: 16.971

8.  Characterization of the Jembrana disease virus tat gene and the cis- and trans-regulatory elements in its long terminal repeats.

Authors:  H Chen; G Wilcox; G Kertayadnya; C Wood
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

9.  Targeting of CDK8 to a promoter-proximal RNA element demonstrates catalysis-dependent activation of gene expression.

Authors:  M O Gold; A P Rice
Journal:  Nucleic Acids Res       Date:  1998-08-15       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.